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The aim
Evaluation of the applicability of immunoblotting for
diagnosing cross reactivity between homologous proteins
present in various sources. Method and material: Group
of 21 patients with birch pollen allergy aged 41,7±5,2
revealing symptoms after eating cross-reacting food and
positive skin tests, or prick by prick tests with native
food allergens. Control group - 7 persons aged 39,8±4,7,
allergic to birch pollen without any symptoms after hav-
ing eaten the above mentioned food. Concentration of
asIgE for birch pollen, apple, carrot and celery allergens
has been measured with EIA method. Concentration of
asIgE against recombinant allergens of birch pollen Bet
v1, Bet v2 and celery Api g1 has been evaluated with
FEIA-UniCAP 100.
As plant material served specially prepared extracts of
apples’, separately peel and pulp, as well as of carrot and
celery. The detection of proteins following the immuno-
bloting was conducted by incubating in the darkness the
nitrocellulose membrane in a buffer solution and peroxi-
dase substrate.
Results
Within the group of 21 patients, 16 have developed
(76,2%) positive Bet v1 reaction, include 4 subjects this
reaction was less significant. The presence of IgE for
Mal d1 in apples fruit was diagnosed in 14 patients
(66,6%), in 3 it was weaker, whereas 7 persons (33,3%)
have not revealed any reaction. Antibodies against Mal
d3 from the apple peel extract was detected in serum of
6 patients (28,65%). The simultaneous presence of IgE
against Mal d1 and Mal d3 proteins was detected in 6
patients. 11 subjects (53,4%) revealed the presence of
sIgE for Api g1, in 4 patients the reaction was weak,
and only 1 person (4,75%) had IgE for Dau c1. Within
the control group, the presence of IgE against birch pro-
teins has been detected in 6 patients, to apple - in 3, to
celery – in 2, to carrot – in 1, which may correspond to
Bet v1, Mal d1, Api g1, and Dau c1. Within this group,
1 patient was positive to protein of <10kDA of apple
peel extract. Positive signal in immunobloting to pro-
teins of 17-18 kDa present in all examined extracts was
detected only in 1 person from patients group as well as
1 from control group.
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